SHH · 688315.SS
Novogene Co., Ltd.
CN¥18.46-CN¥0.79 (-4.1%)
Novogene Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 21.21% below the high.
Loading market information…
SHH · 688677.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:15 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Qingdao NovelBeam Technology Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 71.05% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Qingdao NovelBeam Technology Co.,Ltd.’s forward annual dividend is CN¥0.60 per share, paid annual. The forward yield is 1.21% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Qingdao NovelBeam Technology Co.,Ltd.’s next earnings report is currently expected on Apr 23, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Qingdao NovelBeam Technology Co.,Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Qingdao NovelBeam Technology Co., Ltd. is a global provider of optical components and advanced solutions for the medical, life science, laser, and micro-display projection industries. Its comprehensive offerings include specialized medical endoscopy devices such as endoscopes, camera couplers, camera lenses, and light source modules. Additionally, the company supplies a range of optical products covering medical optics, industrial and laser applications, and biometric systems. Established in 2003, the firm maintains its headquarters in Qingdao, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:30 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Apr 24, 2025 |
| CN¥0.39 |
| CN¥146.89M |
| Q4 2024 | Feb 25, 2025 | CN¥0.32 | CN¥124.16M |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥18.46-CN¥0.79 (-4.1%)
Novogene Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 21.21% below the high.
CN¥15.15-CN¥0.35 (-2.26%)
Zhonghong Pulin Medical Products Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 41.53% below the high.
CN¥6.90+CN¥0.12 (+1.77%)
Jinghua Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.95% below the high.
CN¥5.45+CN¥0.01 (+0.18%)
Blue Sail Medical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 38.83% below the high.
CN¥8.29+CN¥0.02 (+0.24%)
Allmed Medical Products Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 44.36% below the high.
CN¥11.56-CN¥0.44 (-3.67%)
Shenzhen Lifotronic Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 20.6% below the high.
CN¥9.32+CN¥0.08 (+0.87%)
Jiangxi Sanxin Medtec Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 13.54% below the high.
CN¥26.75+CN¥0.49 (+1.87%)
Jianmin Pharmaceutical Group Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.65% below the high.
